After two years and nearly $2 billion in settlements to victims of Yaz blood clots, German drug maker Bayer is finally seeing a drop in the number of lawsuits filed against their popular birth control drugs Yaz and Yasmin.
The Judicial Panel on Multidistrict Litigation, which oversees federal mass tort litigation against hundreds of allegedly dangerous products around the country, reported today that the number of pending Yaz lawsuits had dropped from 9,426 on April 15 to 8,919 as of June 16.
That’s a drop of more than 5% in recent months, the largest since lawsuits against Yaz began years ago. But it comes at a price: Bayer has now spent over $1.75 billion paying out settlements to more than 8,600 women and families.
The average Yaz settlement, according to Bayer, is around $200,000. And they are only considering cases involving deep vein thrombosis (DVT), pulmonary embolism, or stroke for women taking Yaz, Yasmin or a similar generic before mid-2012.
However, Bayer says they will continue to review lawsuits through 2014.
Lawyers are still helping those affected file a claim, and it costs nothing for help unless victims receive an award or settlement.
So far, Bayer says they have faced over 13,000 lawsuits from patients alleging Yaz side effects. However, this is still far less than the more than 20,000 blood clot injuries reported for Yaz or Yasmin to the FDA. Lawyers are surprised so many women have not yet taken advantage of the free help available for themselves and their families.
Elmiron is a mild blood-thinner drug that has been around since 1996 and is prescribed to treat bladder pain or inflammation, a condition called interstitial cystitis.
Since many of the companies that sold asbestos or used it in their products have long since gone out of business, people who are diagnosed with asbestos-related cancers often think it’s too late to file a lawsuit.